Antidepressant activity of alprazolam in a reserpine‐induced model of depression
Vimala H. Sethy, Donald H. Hodges
Abstract
Vimala H. Sethy, Donald H. Hodges
Abstract
Abstract The effect of chronic (14–21 day) administration of reserpine (0.1 mg/kg/day), imipramine (10 mg/kg/day), alprazolam (5, 10 and 15 mg/kg/day), and diazepam (10 and 30 mg/kg/day) on beta‐adrenergic receptors in the cerebral cortex and body weight has been reported in this study. Chronic treatment with both imipramine and alprazolam significantly blocked reserpine‐induced increases in beta‐adrenergic receptors and loss in body weight. However, diazepam under similar conditions had no significant effect.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract The effect of chronic (14–21 day) administration of reserpine (0.1 mg/kg/day), imipramine (10 mg/kg/day), alprazolam (5, 10 and 15 mg/kg/day), and diazepam (10 and 30 mg/kg/day) on beta‐adrenergic receptors in the cerebral cortex and body weight has been reported in this study. Chronic treatment with both imipramine and alprazolam significantly blocked reserpine‐induced increases in beta‐adrenergic receptors and loss in body weight. However, diazepam under similar conditions had no significant effect.
Key concepts: Alprazolam, Reserpine, Imipramine, Diazepam, Antidepressant, Pharmacology, Internal medicine, Endocrinology